18F-Fluorodeoxyglucose positron emission tomography in evaluating treatment response to imatinib or other drugs in gastrointestinal stromal tumors: a systematic review.
Details
Serval ID
serval:BIB_D3D260CD4583
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
18F-Fluorodeoxyglucose positron emission tomography in evaluating treatment response to imatinib or other drugs in gastrointestinal stromal tumors: a systematic review.
Journal
Clinical imaging
ISSN
1873-4499 (Electronic)
ISSN-L
0899-7071
Publication state
Published
Issued date
2012
Peer-reviewed
Oui
Volume
36
Number
3
Pages
167-175
Language
english
Notes
Publication types: Journal Article ; Meta-Analysis ; Review
Publication Status: ppublish
Publication Status: ppublish
Abstract
To systematically review the role of (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography (PET) in evaluating treatment response to imatinib or other drugs in gastrointestinal stromal tumors (GIST).
A comprehensive literature search of published studies through February 2011 in PubMed/MEDLINE and EMBASE databases was performed.
We identified 19 studies including 628 patients with GIST. Main findings of included studies are presented.
(18)F-FDG PET has a significant value in assessing treatment response to imatinib or other drugs in GIST patients. (18)F-FDG PET allows an early assessment of treatment response and is a strong predictor of clinical outcome.
A comprehensive literature search of published studies through February 2011 in PubMed/MEDLINE and EMBASE databases was performed.
We identified 19 studies including 628 patients with GIST. Main findings of included studies are presented.
(18)F-FDG PET has a significant value in assessing treatment response to imatinib or other drugs in GIST patients. (18)F-FDG PET allows an early assessment of treatment response and is a strong predictor of clinical outcome.
Keywords
Antineoplastic Agents/therapeutic use, Benzamides, Female, Fluorodeoxyglucose F18, Gastrointestinal Neoplasms/diagnostic imaging, Gastrointestinal Stromal Tumors/diagnostic imaging, Gastrointestinal Stromal Tumors/epidemiology, Humans, Imatinib Mesylate, Male, Piperazines/therapeutic use, Positron-Emission Tomography/statistics & numerical data, Prevalence, Prognosis, Pyrimidines/therapeutic use, Radiopharmaceuticals, Reproducibility of Results, Sensitivity and Specificity, Treatment Outcome
Pubmed
Web of science
Create date
20/08/2017 21:59
Last modification date
20/08/2019 16:53
Usage data
